Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor α gene and their relationship to bone mass variation in postmenopausal Italian women

被引:167
作者
Becherini, L
Gennari, L
Masi, L
Mansani, R
Massart, F
Morelli, A
Falchetti, A
Gonnelli, S
Fiorelli, G
Tanini, A
Brandi, ML
机构
[1] Univ Florence, Dept Clin Physiopathol, Endocrine Unit, I-50139 Florence, Italy
[2] Scuola Super Sant Anna, Pisa, Italy
[3] Univ Siena, Inst Internal Med, I-53100 Siena, Italy
[4] Univ Florence, Dept Internal Med, Florence, Italy
关键词
D O I
10.1093/hmg/9.13.2043
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bone mineral density (BMD), the major determinant of osteoporotic fracture risk, has a strong genetic component, The discovery that inactivation of estrogen receptor alpha (ER alpha) gene is associated with low BMD indicated ER alpha as a candidate gene for osteoporosis, We have investigated the role of three ER alpha gene polymorphisms [intron 1 PvuII and XbaI RFLPs and TA dinucleotide repeat polymorphism 5' upstream of exon 1] in 610 postmenopausal women, There was a strong linkage disequilibrium between intron 1 polymorphic sites and also between these sites and the microsatellite (TA)(n) dinucleotide polymorphism, with a high degree of coincidence of the short TA alleles and the presence of PvuII and XbaI restriction sites, No significant relationship between intron 1 RFLPs and BMD was observed, A statistically significant correlation between (TA)(n) repeat allelic variants and lumbar BMD was observed (P = 0.04, ANCOVA), with subjects with a low number of repeats (TA < 15) showing the lowest BMD values, We observed a statistically significant difference in the mean +/- SD number of TA repeats between analyzed women with a vertebral fracture (n = 73) and the non-fracture group, equivalent to 2.9 (95% CI 1.56-5.72) increased fracture risk in women with a low number of repeats (TA < 15), We conclude that in this large population sample the (TA)(n) dinucleotide repeat polymorphism at the 5' end of the ER alpha gene accounts for part of the heritable component of BMD and might prove useful in the prediction of vertebral fracture risk in postmenopausal osteoporosis.
引用
收藏
页码:2043 / 2050
页数:8
相关论文
共 54 条
[1]   Identification of an enhancer element in the estrogen receptor upstream region: implications for regulation of ER transcription in breast cancer [J].
Cohn, CS ;
Sullivan, JA ;
Kiefer, T ;
Hill, SM .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1999, 158 (1-2) :25-36
[2]   Selective promoter usage of the human estrogen receptor-α gene and its regulation by estrogen [J].
Donaghue, C ;
Westley, BR ;
May, FEB .
MOLECULAR ENDOCRINOLOGY, 1999, 13 (11) :1934-1950
[3]   EVIDENCE OF ESTROGEN-RECEPTORS IN NORMAL HUMAN OSTEOBLAST-LIKE CELLS [J].
ERIKSEN, EF ;
COLVARD, DS ;
BERG, NJ ;
GRAHAM, ML ;
MANN, KG ;
SPELSBERG, TC ;
RIGGS, BL .
SCIENCE, 1988, 241 (4861) :84-86
[4]  
FLEET JC, 1995, J BONE MINER RES, V10, P985
[5]  
Garnero P, 1996, J BONE MINER RES, V11, P827
[6]   Collagen Iα1 Sp1 polymorphism, bone mass, and bone turnover in healthy French premenopausal women:: The OFELY study [J].
Garnero, P ;
Borel, O ;
Grant, SFA ;
Ralston, SH ;
Delmas, PD .
JOURNAL OF BONE AND MINERAL RESEARCH, 1998, 13 (05) :813-817
[7]   Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: Evidence of multiple gene contribution to bone mineral density [J].
Gennari, L ;
Becherini, L ;
Masi, L ;
Mansani, R ;
Gonnelli, S ;
Cepollaro, C ;
Martini, S ;
Montagnani, A ;
Lentini, G ;
Becorpi, AM ;
Brandi, ML .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (03) :939-944
[8]   Determination of transcription start sites in the human estrogen receptor gene and identification of a novel, tissue-specific, estrogen receptor-mRNA isoform [J].
Grandien, K .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1996, 116 (02) :207-212
[9]   The estrogen receptor gene:: Promoter organization and expression [J].
Grandien, K ;
Berkenstam, A ;
Gustafsson, JÅ .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1997, 29 (12) :1343-1369
[10]   ESTROGEN TARGET TISSUE DETERMINES ALTERNATIVE PROMOTER UTILIZATION OF THE HUMAN ESTROGEN-RECEPTOR GENE IN OSTEOBLASTS AND TUMOR-CELL LINES [J].
GRANDIEN, K ;
BACKDAHL, M ;
LJUNGGREN, O ;
GUSTAFSSON, JA ;
BERKENSTAM, A .
ENDOCRINOLOGY, 1995, 136 (05) :2223-2229